SONA.C
In this summary report, we will take a quick look at the top 5 gainers and losers up or down double digits on the Canadian stock markets. Here is…
Sona Nanotech (SONA.C), a developer of rapid, point-care diagnostic tests, announced today that it is discontinuing its previously announced clinical trial for its COVID-19 rapid, antigen saliva test. “Unfortunately,…
The history of humanity is the history of disease. We’ve mostly bumbled around from plague to plague, blind-sided and punch drunk by the ferocity of our unseen foe. Mostly,…
Sona Nanotech (SONA.C) entered into service and supply agreements with a European-based contract organization to manufacture its COVID-19 rapid response virus detection test yesterday. The company has also entered…